Provides WAT Med’s official announcements, including new product launches, awards, certifications, and other key updates.
VANCOUVER, BC, April 2, 2024 /PRNewswire/ — WAT Medical Enterprise achieves a major milestone: HeadaTerm 2 receives the OTC clearance from the U.S. Food and Drug Administration (FDA), making it
VANCOUVER, BC, Dec. 13, 2023 /PRNewswire/ — Discover Boating Miami International Boat Show (DBMIBS) is the world’s largest boat and yacht show. The convention, which attracts over 100,000 visitors from more than
VANCOUVER, BC, May 8, 2023 /PRNewswire/ — Improving the driving experience of drivers and passengers has been one of the directions of innovation in the automotive industry for many years. To address motion
VANCOUVER, BC, March 20, 2023 /PRNewswire/ — As a proud donor to M.D. Anderson Cancer Center since 2019, WAT Medical Enterprise expands its philanthropic campaign by initiating its Red Cross
VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ — The study recruits patients who suffer from chronic nausea and vomiting. EmeTerm Explore’s antiemetic effectiveness will be tested and measured using subjective responses
VANCOUVER, BC, Dec. 15, 2022 /PRNewswire/ — EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., received its FDA clearance in 2018 as a medical device that manages nausea-induced vomiting. In December 2022, EmeTerm expanded
VANCOUVER, BC, Nov. 1, 2022 /PRNewswire/ — With the foreseeable increase in outdoor travelling in the near future, as well as the ever-expanding prospects of self-driving vehicles that have been reported to
EmeTerm® Fashion has been around for a while. We tested the ability of the device and set customer survey. The aim of this survey is to provide suggestions about improving customer
VANCOUVER, BC, Sept. 27, 2022 /PRNewswire/ — Dr. YongHua Li conducted a clinical trial for EmeTerm, the anti-nausea wristband developed by WAT Medical Enterprise, Ltd., Vancouver, BC, Canada. The study spanned across three hospitals and was aimed
VANCOUVER, BC, Aug. 31, 2022 /PRNewswire/ — WAT Medical is thrilled to introduce its latest innovative technology that would help the millions of people who suffer from nausea and vomiting, the EmeTerm Plus,
Geely Holding Group is committed to becoming a globally competitive and influential smart electric mobility and energy service technology company, with businesses covering automotive upstream and downstream industry chains, smart
Mitacs is a non-profit Canadian research organization that brings together academia researchers and industry experts to conduct studies on innovative science and technologies. WAT Medical’s latest innovation: BPRelief, will be
